Coronavirus update: Eli Lilly staffer tests positive, FDA postpones inspections and AACR is canceled as outbreak roils biopharma

The fallout from the fast-spreading coronavirus pandemic continues to be felt in the biopharma industry.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Coro­n­avirus up­date: Eli Lil­ly staffer tests pos­i­tive, FDA post­pones in­spec­tions and AACR is can­celed as out­break roils bio­phar­ma